Laboratory Investigation
United States and Canadian Academy of Pathology The United States and Canadian Academy of Pathology
LWW Lippincott Williams and Wilkins
publishes Laboratory Investigation
--
                                      View Future Titles
Through Mar 2001
       Archives
Aug 1965 - Feb 2001
       Search Articles
Aug 1965 - Feb 2001
       Browse by Subject
Aug 1965 - Feb 2001
                      
Instructions to authors

Subscriptions

About the journal
   
   Differential Tissular Expression and Localization of Type IV Collagen [alpha]1(IV), [alpha]2(IV), [alpha]5(IV), and [alpha]6(IV) Chains and Their mRNA in Normal Breast and in Benign and Malignant Breast Tumors
Editorial board

Email alerts

'Net Tips

Help

Feedback

Guestbook








  Shogo Nakano, Ken-ichi Iyama, Michio Ogawa, Hidekatsu Yoshioka, Yoshikazu Sado, Toshitaka Oohashi, and Yoshifumi Ninomiya 
   
  Departments of Surgical Pathology (SN, KI), and Surgery II (SN, MO), Kumamoto University School of Medicine, Kumamoto, Department of Biochemistry, Oita Medical University, Oita (HY), Division of Immunology, Shigei Medical Research Institute, Okayama (YS), and Department of Molecular Biology and Biochemistry, Okayama University Medical School, Okayama (TO, YN), Japan 
   
 

Type IV collagen, the major component of basement membrane (BM), is composed of six genetically distinct [alpha] chains. We investigated the cellular regulation and origin of these [alpha](IV) chains in normal and neoplastic breast tissues by immunohistochemistry by using [alpha](IV) chain-specific antibodies and by in situ hybridization. In normal breast, [alpha]1(IV) and [alpha]2(IV) chains were stained in all BM, whereas [alpha]5(IV) and [alpha]6(IV) chains were restrictively localized in a linear pattern in the BM of the mammary gland. Similar immunostaining profiles were observed in benign breast tumors and in the intraductal components of invasive ductal carcinoma. However, in invasive ductal carcinoma, [alpha]1(IV) and [alpha]2(IV) chains were discontinuously or negatively stained in the cancer cell nests, and the assembly of [alpha]5(IV) and [alpha]6(IV) chains into the BM was completely inhibited. Coexpression of [alpha]5(IV) and [alpha]6(IV) chains was related to the localization of [alpha]-smooth muscle actin ([alpha]-SMA)-positive myoepithelial cells. By in situ hybridization, in fibroadenoma and invasive ductal carcinoma, the signals for [alpha]1(IV) and [alpha]2(IV) mRNA were abundant in stromal cells. However, the signals for [alpha]5(IV) and [alpha]6(IV) mRNA were not seen in any of these cells. In contrast, in intraductal papilloma, coexpression of [alpha]1(IV)/[alpha]2(IV) mRNA and [alpha]5(IV)/[alpha]6(IV) mRNA was identified in epithelial cells. The results indicate that the mammary gland forms a second network of BM composed of [alpha]5(IV)/[alpha]6(IV) chains, in addition to the classic network of [alpha]1(IV)/[alpha]2(IV) chains. The expression of type IV collagen [alpha] chains seems to be differentially regulated by the epithelial-myoepithelial interaction and to be associated with the invasive potential of breast cancer. Lab Invest 1999, 79:281-292).